Research based biopharmaceutical company.
Monitored the implementation of P.L. 117-2, the American Rescue Plan and issues regarding COVID relief. Monitored S.Con.Res.14, FY 2022 Budget Resolution. Monitored issues related to the reimbursement of CAR-T cell therapy. H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, H.R. 5376, the Build Back Better Act, and H.R. 19, the Lower Costs, More Cures Act, as they relate to drug pricing. Monitored H.R. 3684, The Infrastructure Investment and Jobs Act, as it relates to sequestration and drug pricing. Monitored issues related to the reimbursement of CAR-T cell therapy. Monitored H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, H.R. 5376, the Build Back Better Act, and H.R. 19/S. 2164, the Lower Costs, More Cures Act, as they relate to drug pricing. Monitored H.R. 3684, The Infrastructure Investment and Jobs Act, as it relates to sequestration and drug pricing.
HCR - Health Issues BUD - Budget/Appropriations GOV - Government Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
MARY BETH SAVARY TAYLOR GREG D'ANGELO MARY BETH SAVARY TAYLOR GREG D'ANGELO BRETT BAKER (U.S. Senate Committee on Finance (Senators Crapo, Grassley, and Hatch)-Deputy Health Policy Director; Health Policy Dir.; Senior Policy Advsr; Policy Advisor. U.S. House of Representatives Committee on Ways and Means (Reps. Camp and Ryan) Prof. Staff) MARY BETH SAVARY TAYLOR GREG D'ANGELO
U.S. Senate Committee on Finance (Senators Crapo, Grassley, and Hatch)-Deputy Health Policy Director; Health Policy Dir.; Senior Policy Advsr; Policy Advisor. U.S. House of Representatives Committee on Ways and Means (Reps. Camp and Ryan) Prof. Staff